Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ibuprofen dose comparison for patent ductus arteriosus in premature infants
ChiCTR-TRC-14004559Phase 4Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Patent ductus arteriosus closure rate. Started May 2014; status: completed.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on ChiCTR-TRC-14004559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004559.